Real-time quantitative PCR (RT–qPCR) and immunofluorescence were used to analyze the expression of ZFX and WNT3 in CML CD34+ cells compared with normal control cells. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.